Acceleron Pharma, Inc.
(NASDAQ : XLRN)

( )
XLRN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.01%72.511.0%$1888.07m
AMGNAmgen, Inc. -2.43%197.811.3%$881.42m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$848.08m
BIIBBiogen, Inc. -7.31%293.271.5%$703.75m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$557.47m
MRNAModerna, Inc. -0.94%29.670.0%$530.64m
ILMNIllumina, Inc. -6.10%256.463.5%$443.43m
ALXNAlexion Pharmaceuticals, Inc. 0.16%89.932.0%$286.49m
AAgilent Technologies, Inc. -3.67%68.991.6%$220.20m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$187.28m
INCYIncyte Corp. 1.30%74.182.5%$178.88m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$164.58m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$163.42m
NVAXNovavax, Inc. 3.31%14.03114.7%$128.96m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$98.37m

Company Profile

Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.